Abstract
Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Current Biotechnology
Title:Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer
Volume: 2 Issue: 1
Author(s): Akhilesh Kumar Singh, Ranjana Bhati, Shilalipi Samantaray and Nirupama Mallick
Affiliation:
Keywords: Inexpensive carbon sources, N-deficiency, P-deficiency, PHAs, Pseudomonas aeruginosa MTCC 7925, RSM, SCL-LCL-PHA co-polymer
Abstract: Pseudomonas aeruginosa MTCC 7925, a sludge isolate, was found to synthesize a novel short-chain-lengthlong- chain-length (SCL-LCL) co-polymer with 3-hydroxybutyric acid (3HB), 3-hydroxyvaleric acid (3HV), 3- hydroxyhexadecanoic acid (3HHD) and 3-hydroxyoctadecanoic acid (3HOD) as constituents. Under batch mode study, cells harvested at the stationary phase of growth depicted maximum PHAs accumulation, i.e. 24% of dry cell weight (dcw) at 48 h of incubation. The co-polymer accumulation was raised to 49% (dcw) under 2% ethanol-supplemented condition. A further, rise up to 78% (dcw) was recorded by optimizing the critical variables by Response Surface Methodology (RSM). When palm oil and its cakes were used as carbon sources, yield of 5.9 g/l was achieved, which was almost 85-fold higher against control. The thermal and mechanical properties of the polymer are comparable with polypropylene and polyethylene, thus opening new possibilities for various industrial applications.
Export Options
About this article
Cite this article as:
Kumar Singh Akhilesh, Bhati Ranjana, Samantaray Shilalipi and Mallick Nirupama, Pseudomonas aeruginosa MTCC 7925: Producer of a Novel SCL-LCLPHA Co-Polymer, Current Biotechnology 2013; 2 (1) . https://dx.doi.org/10.2174/2211550111302010013
DOI https://dx.doi.org/10.2174/2211550111302010013 |
Print ISSN 2211-5501 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-551X |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phosphorylated and O-GlcNAc Modified IRS-1 (Ser1101) and -2 (Ser1149) Contribute to Human Diabetes Type II
Protein & Peptide Letters Current Dental Adhesives Systems. A Narrative Review
Current Pharmaceutical Design Management of Incidental Findings in the Era of Next-generation Sequencing
Current Genomics New Onset ADHD Symptoms in Adolescents and College Students: Diagnostic Challenges and Recommendations
Adolescent Psychiatry Contribution of Mast Cells to Cerebral Aneurysm Formation
Current Neurovascular Research Lack of Data on Depression-like States and Antidepressant Pharmacotherapy in Patients with Epilepsy: Randomised Controlled Trials are Badly Needed
Current Pharmaceutical Design Compensatory Shift of Subcallosal Area and Paraterminal Gyrus White Matter Parameters on DTI in Patients with Alzheimer Disease
Current Alzheimer Research Anti-Inflammatory Therapy for Alzheimer’s Disease from Epidemiological Fact to New Mechanisms of Action
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Exploring the Evidence Implicating the Renin-Angiotensin System (RAS) in the Physiopathology of Mood Disorders
Protein & Peptide Letters Brain Derived Neurotrophic Factor and Cognitive Status: The Delicate Balance Among People Living with HIV, with and without Alcohol Abuse
Current HIV Research Pin1: A New Outlook in Alzheimers Disease
Current Alzheimer Research Therapeutic Noninvasive Brain Stimulation in Alzheimer’s Disease
Current Alzheimer Research Heme Oxygenase-1 in Tumor Biology and Therapy
Current Drug Targets A Legend in Neuroscience (1948-2018) Dr. Stephen D. Skaper, Ph. D
CNS & Neurological Disorders - Drug Targets S100A9 as a Pharmacological Target Molecule in Inflammation and Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Remote Patient Diagnosing Using Health Care Sensor Networks in Rural Areas, Rwanda
Neuroscience and Biomedical Engineering (Discontinued) Metabolism and the Paradoxical Effects of Arsenic: Carcinogenesis and Anticancer
Current Medicinal Chemistry Associations between Alzheimer’s Disease and Blood Homocysteine, Vitamin B<sub>12</sub>, and Folate: A Case-Control Study
Current Alzheimer Research Activation of Melanocortin-4 Receptor by a Synthetic Agonist Inhibits Ethanolinduced Neuroinflammation in Rats
Current Pharmaceutical Design VEGF Mediates ApoE4-Induced Neovascularization and Synaptic Pathology in the Choroid and Retina
Current Alzheimer Research